Find clinical trials for Eczema in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis

Dermatitis

Skin Diseases

Immune System Diseases

Eczematous Skin Diseases

Food Hypersensitivity

Genetic Skin Diseases

Eczema trials near Salt Lake City, UT, USA:

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

This is a first-in-human, Phase 1, double-blind, randomized, placebo-controlled, dose-escalation study evaluating ARQ-234. The study is designed to a...

Enrolling

Eczema

Atopic Dermatitis (AD)

Drug: Placebo

Biological: ARQ-234

Phase 1

Arcutis Biotherapeutics

South Jordan, Utah, United States and 6 other locations

Evaluating Safety and Efficacy of ADX-914 in Patients With Moderate to Severe Atopic Dermatitis (SIGNAL-AD)

This is a phase IIa, randomized, double-blind, placebo-controlled, multi-center proof-of-concept (POC) study in subjects with moderate to severe Atop...

Active, not recruiting

Atopic Dermatitis

Drug: Placebo

Drug: ADX-914

Phase 2

Q32 Bio

Salt Lake City, Utah, United States of America and 27 other locations

A Study of Barzolvolimab in Patients With Atopic Dermatitis

The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis

Active, not recruiting

Atopic Dermatitis

Biological: Barzolvolimab

Drug: Matching placebo

Phase 2

Celldex Therapeutics

South Jordan, Utah, United States and 36 other locations

A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis (AD Up)

The objective of this study is to assess the efficacy and safety of upadacitinib combined with topical corticosteroids (TCS) for the treatment of ado...

Active, not recruiting

Atopic Dermatitis

Drug: Placebo

Drug: Upadacitinib

Phase 3